Akamai CEO, Twilio CEO & Homework: MindMedicine
Jun 15, 2021•45 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
For the best experience, listen in Metacast app for iOS or Android